These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19651504)

  • 1. Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD.
    Magnussen H; Watz H; Zimmermann I; Macht S; Greguletz R; Falques M; Jarreta D; Garcia Gil E
    Respir Med; 2009 Dec; 103(12):1832-7. PubMed ID: 19651504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genuair® inhaler: a novel, multidose dry powder inhaler.
    Chrystyn H; Niederlaender C
    Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler.
    Newman SP; Sutton DJ; Segarra R; Lamarca R; de Miquel G
    Respiration; 2009; 78(3):322-8. PubMed ID: 19451700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.
    Marth K; Schuller E; Pohl W
    Respir Med; 2015 May; 109(5):616-24. PubMed ID: 25796962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD.
    Gelb AF; Tashkin DP; Make BJ; Zhong X; Garcia Gil E; Caracta C;
    Respir Med; 2013 Dec; 107(12):1957-65. PubMed ID: 23916502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants.
    Jansat JM; Lamarca R; de Miquel G; Schrödter A; Miletzki B; Gurniak M
    J Clin Pharmacol; 2009 Oct; 49(10):1239-46. PubMed ID: 19592595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Page CP; Matera MG
    Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients.
    Joos GF; Schelfhout VJ; Pauwels RA; Kanniess F; Magnussen H; Lamarca R; Jansat JM; Garcia Gil E
    Respir Med; 2010 Jun; 104(6):865-72. PubMed ID: 20044242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
    Al-Showair RA; Tarsin WY; Assi KH; Pearson SB; Chrystyn H
    Respir Med; 2007 Nov; 101(11):2395-401. PubMed ID: 17629471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.
    Jones P
    Adv Ther; 2013 Apr; 30(4):354-68. PubMed ID: 23553509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of dry powder inhalers in COPD.
    Wilson DS; Gillion MS; Rees PJ
    Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.
    Pascual S; Feimer J; De Soyza A; Sauleda Roig J; Haughney J; Padullés L; Seoane B; Rekeda L; Ribera A; Chrystyn H
    NPJ Prim Care Respir Med; 2015 Apr; 25():15018. PubMed ID: 25927321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genuair is a good inhaler but an indirect comparison with other dry powder inhalers is inadequate.
    Cazzola M
    Respiration; 2009; 78(3):249-51; discussion 252. PubMed ID: 19546520
    [No Abstract]   [Full Text] [Related]  

  • 20. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
    Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.